45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
80,206
Insurances with rates
26
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 50010218 | Imjudo (tremelimumab-ACTL) 20 mg/mL Inj 15mL | $347,474 | $173,737 | — | — | 4 |
| 50010218 | Imjudo (tremelimumab-ACTL) 20 mg/mL Inj 15mL | $347,474 | $173,737 | — | — | 8 |
| 50010218 | Imjudo (tremelimumab-ACTL) 20 mg/mL Inj 15mL | $347,474 | $173,737 | — | — | 5 |
| 50010242 | Pegloticase (Krystexxa) 8mg/mL Inj | $267,574 | $133,787 | — | — | 4 |
| 50010242 | Pegloticase (Krystexxa) 8mg/mL Inj | $267,574 | $133,787 | — | — | 8 |
| 50010242 | Pegloticase (Krystexxa) 8mg/mL Inj | $267,574 | $133,787 | — | — | 5 |
| 50010098 | Alemtuzumab 10mg/mL Inj 1.2mL dns | $262,477 | $131,238 | — | — | 4 |
| 50010098 | Alemtuzumab 10mg/mL Inj 1.2mL dns | $262,477 | $131,238 | — | — | 8 |
| 50010098 | Alemtuzumab 10mg/mL Inj 1.2mL dns | $262,477 | $131,238 | — | — | 5 |
| 50010162 | Ustekinumab 90 mg/mL inj Syr dns | $253,336 | $126,668 | — | — | 4 |
| 50010162 | Ustekinumab 90 mg/mL inj Syr dns | $253,336 | $126,668 | — | — | 10 |
| 50010162 | Ustekinumab 90 mg/mL inj Syr dns | $253,336 | $126,668 | — | — | 5 |
| 50300287 | Sipuleucel-T >/ 50 million cells / 250mL LR | $253,329 | $126,665 | — | — | 4 |
| 50300287 | Sipuleucel-T >/ 50 million cells / 250mL LR | $253,329 | $126,665 | — | — | 8 |
| 50300287 | Sipuleucel-T >/ 50 million cells / 250mL LR | $253,329 | $126,665 | — | — | 5 |
| 50010207 | Ocrelizumab 300 mg/10 mL Inj | $175,832 | $87,916 | — | — | 4 |
| 50010207 | Ocrelizumab 300 mg/10 mL Inj | $175,832 | $87,916 | — | — | 8 |
| 50010207 | Ocrelizumab 300 mg/10 mL Inj | $175,832 | $87,916 | — | — | 5 |
| 50010215 | Teprotumumab-TRBW (Tepezza) 500 mg Inj | $156,223 | $78,112 | — | — | 4 |
| 50010215 | Teprotumumab-TRBW (Tepezza) 500 mg Inj | $156,223 | $78,112 | — | — | 8 |
| 50010215 | Teprotumumab-TRBW (Tepezza) 500 mg Inj | $156,223 | $78,112 | — | — | 5 |
| VVMC-9838552 | DEV VENTRC IMPELLA 5.5 SMRTSST | $141,750 | $70,875 | — | — | 4 |
| VVMC-9838552 | DEV VENTRC IMPELLA 5.5 SMRTSST | $141,750 | $70,875 | — | — | 9 |
| VVMC-9838552 | DEV VENTRC IMPELLA 5.5 SMRTSST | $141,750 | $70,875 | — | — | 4 |
| VVMC-9794381 | DEVICE VENTRC IMPELLA 5.5 | $129,150 | $64,575 | — | — | 4 |
| VVMC-9794381 | DEVICE VENTRC IMPELLA 5.5 | $129,150 | $64,575 | — | — | 9 |
| VVMC-9794381 | DEVICE VENTRC IMPELLA 5.5 | $129,150 | $64,575 | — | — | 4 |
| 50300261 | Pertuzumab 1200mg-Trastuz 600mg HY-zzxf/ 15mL inj | $124,231 | $62,116 | — | — | 4 |
| 50300261 | Pertuzumab 1200mg-Trastuz 600mg HY-zzxf/ 15mL inj | $124,231 | $62,116 | — | — | 8 |
| 50300261 | Pertuzumab 1200mg-Trastuz 600mg HY-zzxf/ 15mL inj | $124,231 | $62,116 | — | — | 5 |
| 50010213 | Tildrakizumab-asmn 100 mg/mL inj syringe | $119,652 | $59,826 | — | — | 4 |
| 50010213 | Tildrakizumab-asmn 100 mg/mL inj syringe | $119,652 | $59,826 | — | — | 8 |
| 50010213 | Tildrakizumab-asmn 100 mg/mL inj syringe | $119,652 | $59,826 | — | — | 5 |
| 50010115 | Ipilimumab 5mg/mL inj 40mL | $116,041 | $58,021 | — | — | 4 |
| 50010115 | Ipilimumab 5mg/mL inj 40mL | $116,041 | $58,021 | — | — | 8 |
| 50010115 | Ipilimumab 5mg/mL inj 40mL | $116,041 | $58,021 | — | — | 5 |
| 50300272 | Luspatercept-aamt 75 mg Inj | $115,685 | $57,843 | — | — | 4 |
| 50300272 | Luspatercept-aamt 75 mg Inj | $115,685 | $57,843 | — | — | 8 |
| 50300272 | Luspatercept-aamt 75 mg Inj | $115,685 | $57,843 | — | — | 5 |
| VVMC-9816454 | KIT VAL AO SAP3 ULT RSL 20MM | $107,100 | $53,550 | — | — | 4 |
| VVMC-9816454 | KIT VAL AO SAP3 ULT RSL 20MM | $107,100 | $53,550 | — | — | 9 |
| VVMC-9816455 | KIT VAL AO SAP3 ULT RSL 23MM | $107,100 | $53,550 | — | — | 4 |
| VVMC-9816455 | KIT VAL AO SAP3 ULT RSL 23MM | $107,100 | $53,550 | — | — | 9 |
| VVMC-9816456 | KIT VAL AO SAP3 ULT RSL 26MM | $107,100 | $53,550 | — | — | 4 |
| VVMC-9816456 | KIT VAL AO SAP3 ULT RSL 26MM | $107,100 | $53,550 | — | — | 9 |
| VVMC-9816457 | KIT VAL AO SAP3 ULT RSL 29MM | $107,100 | $53,550 | — | — | 4 |
| VVMC-9816457 | KIT VAL AO SAP3 ULT RSL 29MM | $107,100 | $53,550 | — | — | 9 |
| VVMC-9836972 | SAPIEN 3 ULTRA RESILIA TRASCATHETER HEART VALVE 20 | $107,100 | $53,550 | — | — | 4 |
| VVMC-9836972 | SAPIEN 3 ULTRA RESILIA TRASCATHETER HEART VALVE 20 | $107,100 | $53,550 | — | — | 9 |
| VVMC-9836974 | SAPIEN 3 ULTRA RESILIA TRASCATHETER HEART VALVE 23 | $107,100 | $53,550 | — | — | 4 |
Showing top 50 of 80,206 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.